Dow Forecast, price target & analysts
Dow Target price 2025 - Analyst rating & recommendation
Dow Classifications & Recommendation:
Dow Price Target
| Target Price | $33.63 |
| Price | $30.19 |
| Potential | 11.40% |
| Number of Estimates | 19 |
| 19 Analysts have issued a price target Dow 2026 . The average Dow target price is $33.63. This is 11.40% higher than the current stock price. The highest price target is $56.00 85.49% , the lowest is $27.00 10.57% . | |
| A rating was issued by 26 analysts: 5 Analysts recommend Dow to buy, 19 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Dow stock has an average upside potential 2026 of 11.40% . Most analysts recommend the Dow stock at Hold. |
Sales and Margin forecast 2025, 2026 & 2027
16 Analysts have issued a sales forecast Dow 2025 . The average Dow sales estimate is $41.8b . This is 2.04% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $42.4b 0.63% , the lowest is $40.6b 4.67% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $43.0b | 3.72% |
|---|---|---|
| 2025 | $41.8b | 2.80% |
| 2026 | $43.1b | 3.30% |
| 2027 | $44.7b | 3.56% |
19 Analysts have issued an Dow EBITDA forecast 2025. The average Dow EBITDA estimate is $4.1b . This is 5.92% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $4.5b 2.10% , the lowest is $3.6b 17.67% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $5.0b | 3.30% |
|---|---|---|
| 2025 | $4.1b | 16.98% |
| 2026 | $5.1b | 24.11% |
| 2027 | $5.8b | 13.99% |
EBITDA Margin
| 2024 | 11.54% | 0.44% |
|---|---|---|
| 2025 | 9.86% | 14.56% |
| 2026 | 11.84% | 20.08% |
| 2027 | 13.03% | 10.05% |
5 Dow Analysts have issued a net profit forecast 2025. The average Dow net profit estimate is $-152m . This is 153.78% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $28.3m 90.00% , the lowest is $-269m 195.00% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $1.1b | 91.46% |
|---|---|---|
| 2025 | $-152m | 113.70% |
| 2026 | $895m | 688.29% |
| 2027 | $1.4b | 54.13% |
Net Margin
| 2024 | 2.58% | 98.85% |
|---|---|---|
| 2025 | -0.36% | 113.94% |
| 2026 | 2.07% | 675.00% |
| 2027 | 3.09% | 49.28% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
5 Analysts have issued a Dow forecast for earnings per share. The average Dow EPS is $-0.22 . This is 155.00% lower than earnings per share in the financial year 2024. The highest EPS forecast is $0.04 90.00% , the lowest is $-0.38 195.00% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $1.57 | 91.46% |
|---|---|---|
| 2025 | $-0.22 | 114.01% |
| 2026 | $1.27 | 677.27% |
| 2027 | $1.95 | 53.54% |
P/E ratio
| Current | 75.46 | 112.98% |
|---|---|---|
| 2025 | -140.33 | 285.97% |
| 2026 | 23.85 | 117.00% |
| 2027 | 15.48 | 35.09% |
Based on analysts' sales estimates for 2025, the Dow stock is valued at an EV/Sales of 0.91 and an P/S ratio of 0.51 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 0.89 | 29.92% |
|---|---|---|
| 2025 | 0.91 | 1.90% |
| 2026 | 0.88 | 3.20% |
| 2027 | 0.85 | 3.44% |
P/S ratio
| Current | 0.50 | 47.83% |
|---|---|---|
| 2025 | 0.51 | 2.08% |
| 2026 | 0.49 | 3.19% |
| 2027 | 0.48 | 3.44% |
Current Dow Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Goldman Sachs |
Neutral
➜
Neutral
|
Unchanged | Apr 29 2025 |
| Fermium Research |
Hold
➜
Buy
|
Upgrade | Apr 25 2025 |
| Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 24 2025 |
| B of A Securities |
Buy
➜
Underperform
|
Downgrade | Apr 15 2025 |
| Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Apr 09 2025 |
| Piper Sandler |
Neutral
➜
Neutral
|
Unchanged | Apr 07 2025 |
| UBS |
Neutral
➜
Neutral
|
Unchanged | Apr 07 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Goldman Sachs:
Neutral
➜
Neutral
|
Apr 29 2025 |
|
Upgrade
Fermium Research:
Hold
➜
Buy
|
Apr 25 2025 |
|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Apr 24 2025 |
|
Downgrade
B of A Securities:
Buy
➜
Underperform
|
Apr 15 2025 |
|
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Apr 09 2025 |
|
Unchanged
Piper Sandler:
Neutral
➜
Neutral
|
Apr 07 2025 |
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Apr 07 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
